Table 6.

Concomitant vitamin D and phosphate binder use during titration and maintenance phases

Vitamin and phosphate binder use during titration and maintenance phases	Total (n = 589) n (%)
Vitamin D use
Started using vitamin D after first dose of study drug	130 (22)
Never used/started vitamin D during time period	109 (19)
Used/started vitamin D during the time period	476 (81)
Calcitriol, i.v. only	78 (13)
Calcitriol, p.o. only	98 (17)
Paricalcitol only	143 (24)
Doxercalciferol only	17 (3)
Alfacalcidol, i.v. only	17 (3)
Alfacalcidol, p.o. only	58 (10)
Other or multiple vitamin D use	65 (11)
Phosphate binder
Started using phosphate binder after the first dose of study drug	20 (3)
Never used/started phosphate binder during the time period	14 (2)
Used/started phosphate binder during the time period	571 (97)
Aluminum-containing only	13 (2)
Calcium-containing only	205 (35)
Sevelamer HCl only	117 (20)
Other or multiple phosphate binder use	236 (40)